Completed PHASE2 INTERVENTIONAL 2-arm NCT00406536

Study of LYM-X-SORB™ to Improve Fatty Acid and Choline Status in Children With CF and PI

Phase II Study: LYM-X-SORB™, an Organized Lipid Matrix: Fatty Acids and Choline in CF

Sponsor: Avanti Polar Lipids, Inc.

Conditions Cystic Fibrosis Pancreatic Insufficiency

Interventions Lym-X-Sorb powder Placebo powder

Updated 5 times since 2017 Last updated: Jan 11, 2013 Started: Jan 31, 2007 Primary completion: Jun 30, 2012 Completion: Jun 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Cystic Fibrosis and Pancreatic Insufficiency and is currently completed. Avanti Polar Lipids, Inc. leads this study, which shows 5 recorded versions since 2007 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Jan 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Avanti Polar Lipids, Inc.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Data source: Avanti Polar Lipids, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Philadelphia, United States